Lipinski's Rule of Five¶
Flag possible oral absorption or permeation difficulty from four empirical molecular-property thresholds, without treating the alert as a verdict.
Core Idea¶
Lipinski's Rule of Five is a quick, empirical warning about possible poor oral absorption or permeation in small-molecule discovery. It compares hydrogen-bond donor and acceptor counts, molecular weight, and calculated lipophilicity with four source-specific thresholds: more than 5 donors, more than 10 acceptors, mass above 500, and CLogP above 5, or MLogP above 4.15 under the original alternative convention. Exceedance raises risk; staying within bounds does not prove oral bioavailability. The original 1997 abstract does not visibly establish the frozen seed's hard “more than one violation” rejection cutoff, so that stronger claim is not made here.[^ref-c3fecc5cabc3]
This is a property heuristic, not a biological-activity, safety, efficacy or clinical rule. It is also not a measured absorption test. The four descriptors focus early attention where more detailed empirical assessment may be needed.[^ref-c3fecc5cabc3]
Scope of Application¶
Lipinski and colleagues introduced the warning in a discovery setting where high-throughput-screening leads tended to be larger, more lipophilic, and less soluble than earlier leads. They separately discuss development-stage solubility prediction as a harder, measurement-dependent task.[^ref-c3fecc5cabc3] Quinn and colleagues later used Lipinski violation counts to profile a natural-product library: 60% of 126,140 dictionary compounds and 85% of 814 selected isolated products had zero violations. That is a literal library-composition application, not proof of therapeutic performance or a reason to reject all other natural products.[^ref-c85e0ee26dd3]
Shultz's retrospective comparison found changes in the property ranges of approved oral drugs over two decades; Veber and colleagues found that mass 500 alone did not significantly discriminate rat oral bioavailability in their candidate dataset. These are scope and calibration checks, not replacements silently inserted into the four original criteria.[ref-da2e9ff53f47][ref-49b6922b1810]
Clarity¶
“Compliant” means a structure falls within a property-alert region; “orally available” is an empirical outcome involving additional mechanisms. The original thresholds use greater than, and the alternative MLogP number is not interchangeable with CLogP 5. A violation count describes exceeded comparisons, not automatically a verified pass/fail line or a molecule's measured outcome.[ref-c3fecc5cabc3][ref-c85e0ee26dd3]
Manages Complexity¶
Four readily obtained descriptors compress a large oral-exposure question into a fast prioritization signal. That saves early decision effort but omits mechanisms, formulation, measured solubility, permeability and other properties. The shortcut is useful precisely when its omissions are kept visible rather than mistaken for a complete model.[ref-c3fecc5cabc3][ref-49b6922b1810]
Abstract Reasoning¶
First confirm that the question concerns an oral candidate's absorption or permeation risk. Record the four descriptors, including which log P convention was used; compare each with its corresponding original threshold. Interpret exceeded thresholds as reasons for further assessment, not terminal rejection, and seek measured and class-specific evidence before consequential conclusions. A candidate with no alerts is not thereby proven effective, safe, or orally bioavailable.[ref-c3fecc5cabc3][ref-da2e9ff53f47]
Knowledge Transfer¶
Discovery-lead triage and natural-product library profiling preserve the same rule roles: oral-property question, four descriptors, threshold comparisons and fallible alert. One prioritizes follow-up for discovery leads; the other characterizes a library. Outside medicinal chemistry, the portable simplified-rule pattern belongs to live Heuristic, the proposed strict parent. The Rule of Five's exact numbers and oral absorption interpretation do not transfer literally to unrelated domains.[ref-c3fecc5cabc3][ref-c85e0ee26dd3]
[^ref-c3fecc5cabc3]: Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and Paul J. Feeney, “Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings”, Advanced Drug Delivery Reviews 23(1–3) (1997), 3–25. Original publisher abstract inspected; full article not inspected. [^ref-c85e0ee26dd3]: Ronald J. Quinn, Anthony R. Carroll, Ngoc B. Pham, Paul Baron, Meredith E. Palframan, Lekha Suraweera, Gregory K. Pierens and Sorel Muresan, “Developing a drug-like natural product library”, Journal of Natural Products 71(3) (2008), 464–468. Original-study indexed abstract; full text not inspected. [^ref-da2e9ff53f47]: Michael D. Shultz, “Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs”, Journal of Medicinal Chemistry 62(4) (2019), 1701–1714. Original publisher/indexed abstract; full text not inspected. [^ref-49b6922b1810]: Daniel F. Veber, Stephen R. Johnson, Hung-Yuan Cheng, Brian R. Smith, Keith W. Ward and Kenneth D. Kopple, “Molecular properties that influence the oral bioavailability of drug candidates”, Journal of Medicinal Chemistry 45(12) (2002), 2615–2623. Original-study indexed abstract, limited to its rat-candidate dataset.
Relationships to Other Abstractions¶
Current abstraction Lipinski's Rule of Five Domain-specific
Parents (1) — more general patterns this builds on
-
Lipinski's Rule of Five is a kind of Heuristic Prime
The Rule of Five is a simplified fallible property-alert heuristic for oral-candidate assessment.
Hierarchy paths (2) — routes to 2 parentless roots
- Lipinski's Rule of Five → Heuristic → Approximation → Representation → Abstraction
- Lipinski's Rule of Five → Heuristic → Trade-offs → Constraint
Neighborhood in Abstraction Space¶
Lipinski's Rule of Five sits in a sparse region of the domain-specific corpus (85th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.
Family — Clinical Trial Design & Drug Safety (22 abstractions)
Nearest neighbors
- YARA — 0.82
- Diagnostic Method — 0.82
- Spectrum Bias — 0.82
- Optimality criterion — 0.81
- Fragment-Based Lead Discovery — 0.81
Computed from structural-signature embeddings · 2026-10-08